Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist



Status:Completed
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:18 - 40
Updated:4/21/2016
Start Date:January 2014
End Date:March 2014

Use our guide to learn which trials are right for you!

The objective of this study is to compare the clinical performance of ProClear 1-Day versus
1-Day Acuvue Moist each for one week of daily disposable wear.

The purpose of this cross-over study is to evaluate the clinical performance of the
ProClear-1 Day in comparison with 1-Day Acuvue® Moist®. In particular, the study will focus
on lens wearing comfort.

Inclusion Criteria:

A person is eligible for inclusion in the study if he/she:

- Is between 18 and 40 years of age (inclusive)

- Have the use of a mobile phone to send and receive text messages throughout the day
for the duration of the study.

- Has had a self-reported visual exam in the last two years

- Is an adapted soft CL (Contact Lens) wearer

- Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per
day, assuming there are no contraindications for doing so

- Has a CL spherical prescription between - 1.00 and - 6.00 (inclusive)

- Has less than 0.75D (Diopters) spectacle cylinder in each eye.

- Is correctable to a visual acuity of 20/25 or better in both eyes

- Has clear corneas and no active ocular disease

- Has read, understood and signed the information consent letter.

- Is willing to comply with the wear schedule (at least 40 hrs per week)

- Is willing to comply with the visit schedule

Exclusion Criteria:

A person will be excluded from the study if he/she:

- Has never worn contact lenses before.

- Currently wears rigid gas permeable contact lenses.

- Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)

- Has a CL prescription outside the range of - 1.00 to -6.00D

- Has a spectacle cylinder greater than -0.50D of cylinder in either eye.

- Has best corrected spectacle distance vision worse then 20/25 in either eye.

- Has any systemic disease affecting ocular health.

- Is using any systemic or topical medications that will affect ocular health.

- Has any ocular pathology or severe insufficiency of lacrimal secretion

- Has persistent, clinically significant corneal or conjunctival staining

- Has active neovascularization or any central corneal scars.

- Is aphakic.

- Is presbyopic.

- Has undergone corneal refractive surgery.

- Is participating in any other type of eye related clinical or research study.
We found this trial at
4
sites
New Albany, Ohio 43054
13
mi
from 43215
New Albany, OH
Click here to add this to my saved trials
Athens, Ohio 45701
65
mi
from 43215
Athens, OH
Click here to add this to my saved trials
Lake Zurich, Illinois 60047
305
mi
from 43215
Lake Zurich, IL
Click here to add this to my saved trials
Phoenix, Arizona 85032
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials